Takahashi-Yanaga Fumi, Shiraishi Fumie, Hirata Masato, Miwa Yoshikazu, Morimoto Sachio, Sasaguri Toshiyuki
Department of Clinical Pharmacology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Biochem Biophys Res Commun. 2004 Apr 2;316(2):411-5. doi: 10.1016/j.bbrc.2004.02.061.
Glycogen synthase kinase-3beta (GSK-3beta) can be associated with several proteins in cell. We analyzed the immunoprecipitates by an anti-GSK-3beta antibody from cell lysate of human fibroblasts and found that this protein was co-precipitated with mitogen-activated protein kinase kinase (MEK1/2). U0126, a MEK1/2 inhibitor, inhibited tyrosine phosphorylation of GSK-3beta, suggesting that MEK1/2 was involved in the phosphorylation of Tyr(216) in GSK-3beta. In vitro kinase assay was carried out using a recombinant human active MEK1 and we found that GSK-3beta was phosphorylated on Tyr(216) by this kinase in a dose- and time-dependent manner. Further, the pretreatment of fibroblasts with U0126 inhibited serum-induced nuclear translocation of GSK-3beta. These results suggested that MEK1/2 induces tyrosine phosphorylation of GSK-3beta and this cellular event might induce nuclear translocation of GSK-3beta. This is the first report to suggest that MEK1/2 phosphorylates not only ERK1/2 but also GSK-3beta.
糖原合酶激酶-3β(GSK-3β)可与细胞中的多种蛋白质相关联。我们用人成纤维细胞裂解液的抗GSK-3β抗体分析免疫沉淀产物,发现该蛋白与丝裂原活化蛋白激酶激酶(MEK1/2)共沉淀。MEK1/2抑制剂U0126抑制了GSK-3β的酪氨酸磷酸化,表明MEK1/2参与了GSK-3β中Tyr(216)的磷酸化。使用重组人活性MEK1进行体外激酶测定,我们发现该激酶以剂量和时间依赖性方式使GSK-3β的Tyr(216)磷酸化。此外,用U0126预处理成纤维细胞可抑制血清诱导GSK-3β的核转位。这些结果表明MEK1/2诱导GSK-3β的酪氨酸磷酸化,并且这一细胞事件可能诱导GSK-3β的核转位。这是首次报道表明MEK1/2不仅使ERK1/2磷酸化,还使GSK-3β磷酸化。